Methods for identifying targets that enhance gibberellin production and their applications
By using the CRISPR/Cas9 system and NHEJ random integration technology, recombinant strains with high gibberellin production were screened from *Fujikura gibberellin*, solving the problem of increasing gibberellin yield in existing technologies and providing a new method for gibberellin production.
Patent Information
- Application Number
- CN202310432198.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2023-04-20
- Publication Date
- 2026-11-17
- Estimated Expiration
- 2043-04-20
AI Technical Summary
Current technologies cannot increase the gibberellin yield of *Fujikura gibberellin* by integrating genes outside the gibberellin synthesis pathway, making it difficult to overcome the yield bottleneck.
The modified gene was knocked out using the CRISPR/Cas9 system, and the modified gene was introduced into the gene-deficient strain using NHEJ random integration technology. The transformed strain with the highest gibberellin yield was screened, and the integration target of the modified gene was identified by reverse PCR.
This study enabled the efficient screening of high-yielding gibberellin strains, revealed the intrinsic mechanism affecting gibberellin yield, provided a new platform for gibberellin production, and improved the gibberellin yield of *Fujikura gibberellin*.
Smart Images

Figure CN116376726B_ABST
Abstract
Description
Technical Field
[0001] This invention relates to the field of genetic engineering, and more specifically, to a method for identifying targets that increase gibberellin production and its application. Background Technology
[0002] DNA double-strand breaks (DSBs) pose a serious threat to cells. Repair pathways primarily include non-homologous end joining (NHEJ) and homologous recombination (HR). HR is a fine-grained repair method that integrates donor DNA fragments into target sites on the genome to repair DSBs. In contrast, NHEJ repair does not require the recognition of large homologous sequences; it proceeds directly by joining a few bases at the ends, making it a more error-prone repair method. For eukaryotes, NHEJ repair is dominant. It can effectively repair DSBs even without a template. Unlike HR, which is limited by homologous templates, NHEJ allows the target gene to be randomly inserted into different locations in the genome, resulting in recombinant strains with varying gene expression levels.
[0003] As the dominant host for the plant growth hormone gibberellin, *Gibberella fuciformis* is considered an excellent cell factory for industrial fermentation production. However, it is a non-model bacterium with a complex metabolic mechanism, and fermentation engineering and mutagenesis breeding can no longer further address the yield bottleneck. To obtain high-performance, stably heritable recombinant strains, synthetic biology modification techniques have received increasing attention. Since the establishment of homologous recombination technology in *Gibberella fuciformis*, key genes in the gibberellin synthesis pathway have been identified and overexpressed. However, there are currently no studies or reports on improving the gibberellin production capacity of strains by integrating genes other than those key genes in the gibberellin synthesis pathway. Summary of the Invention
[0004] The purpose of this invention is to overcome the problems existing in the prior art and provide a method for identifying targets for increasing gibberellin production and its application. This method can identify new targets for increasing gibberellin production, obtain recombinant strains with high gibberellin production, and provide a new platform for the metabolic engineering modification of gibberellin-producing bacteria.
[0005] To achieve the above objectives, the first aspect of the present invention provides a method for identifying targets for increasing gibberellin production, the method comprising the following steps:
[0006] (1) Knock out the modified gene in the starting strain to obtain a modified gene-deficient strain;
[0007] (2) Prepare protoplasts of the gene-deficient bacteria, randomly integrate the protoplasts with the gene using NHEJ to obtain N transforming strains, and screen the N transforming strains to obtain the transforming strain with the highest gibberellin production as the target strain.
[0008] (3) The target strain is identified by reverse PCR to identify the integration target of the modified gene on the starting strain, so as to obtain the target for increasing gibberellin production.
[0009] Preferably, the modified gene is a nitrate reductase gene.
[0010] Preferably, the nucleotide sequence of the nitrate reductase gene is shown in SEQ ID NO: 1.
[0011] Preferably, the starting strain is *Fujikura fusiforme*, more preferably *Fujikura fusiforme* with accession number CCTCC NO:M2015614.
[0012] Preferably, the knockout process in step (1) includes knocking out the modified gene using a CRISPR / Cas9 system.
[0013] Preferably, the knockout backbone of the CRISPR / Cas9 system is a pFfCas9-sgRNA plasmid, the components of which include the Cas9 gene, the promoter pTRPC, and the strong RNA polymerase III promoter 5S rRNA; the internal design of the pFfCas9-sgRNA plasmid includes the stuⅠ site for inserting N20 into the nutrient selection marker niaD.
[0014] Preferably, the nucleotide sequence of the sgRNA is shown in SEQ ID NO: 9, the nucleotide sequence of the 5S rRNA is shown in SEQ ID NO: 10, and the nucleotide sequence of the N20 is shown in SEQ ID NO: 11.
[0015] Preferably, the NHEJ random integration process in step (2) includes: mixing the protoplast, the modified gene, and PEG6000 and STC buffer to obtain a suspension, and placing the suspension on a solid regeneration plate for transformation culture.
[0016] Preferably, the culture medium of the solid regeneration plate contains: 15-25 g / L glucose, 5-8 g / L yeast basal medium, 0.5-1 g / L sodium nitrate, 15-25 g / L agar powder, and 0.3-0.8 mol / L sucrose.
[0017] Preferably, the conditions for the transformation culture include: a temperature of 25-30℃ and a time of 4-6 days.
[0018] Preferably, the screening process in step (2) includes: sequentially subculturing the transformed strain and fermenting it.
[0019] Preferably, the culture medium for subculture contains: 15-25 g / L glucose, 5-8 g / L yeast basal medium, 0.5-1 g / L sodium nitrate, 15-25 g / L agar powder, and 0.3-0.8 mol / L sucrose.
[0020] Preferably, the subculture conditions include a temperature of 25-30℃ and a time of 4-6 days.
[0021] Preferably, the culture medium of fermentation culture I contains: 40-120 g / L carbon source, 25-40 g / L nitrogen source, 0.8-1.6 g / L soybean oil, 0.8-1.6 g / L MgSO4·7H2O, 0.2-0.5 g / L (NH4)2SO4, 1.5-4 g / L KH2PO4, 0.05-0.1 g / L ZnSO4, and 0.05-0.1 g / L MnSO4.
[0022] Preferably, the conditions for fermentation culture I include: an inoculum size of 8-12% by volume, a temperature of 25-30°C, a rotation speed of 200-250 rpm, and a time of 8-12 days.
[0023] A second aspect of the present invention provides the application of the above-described identification method in increasing gibberellin yield.
[0024] A third aspect of the present invention provides a recombinant strain, which is a target strain obtained by treating the starting strain using the identification method described above.
[0025] Preferably, the modified gene is a nitrate reductase gene, and the integration target is a dicarboxylic acid transporter site.
[0026] Preferably, the nucleotide sequence of the nitrate reductase gene is shown in SEQ ID NO: 1.
[0027] Preferably, the starting strain is *Fujikura fusiforme*, more preferably *Fujikura fusiforme* with accession number CCTCC NO:M2015614.
[0028] The fourth aspect of the present invention provides a method for preparing gibberellin, the method comprising: inoculating the above-mentioned recombinant strain into a fermentation medium for fermentation culture II.
[0029] Preferably, the conditions for the fermentation culture II include: an inoculum size of 8-12% by volume, a temperature of 25-30°C, a rotation speed of 200-250 rpm, and a time of 8-12 days.
[0030] Preferably, the fermentation medium contains: 40-120 g / L carbon source, 25-40 g / L nitrogen source, 0.8-1.6 g / L soybean oil, 0.8-1.6 g / L MgSO4·7H2O, 0.2-0.5 g / L (NH4)2SO4, 1.5-4 g / L KH2PO4, 0.05-0.1 g / L ZnSO4, and 0.05-0.1 g / L MnSO4.
[0031] The beneficial effects of the present invention through the above technical solution are as follows:
[0032] The present invention provides a method for identifying targets for increasing gibberellin production. Based on a random integration method using non-terminal homologous recombination, molecular modification targets of gibberellin-producing bacteria are obtained. The modified gene expression cassette is introduced into gene-deficient bacteria using DNA random integration technology, causing the modified gene to randomly integrate into the chromosome of the gene-deficient bacteria, thereby forming multiple gene-deficient bacterial transformants. These transformants serve as a mutant library for gibberellin production. Fermentation experiments are conducted on the transformants to screen for high-yielding strains with increased gibberellin production. Reverse PCR technology is used to identify the location of the integrated modified gene in the chromosome, which is beneficial for identifying new targets for increasing gibberellin production. Simultaneously, the target strains obtained by this method can be used as recombinant strains with high gibberellin production.
[0033] More preferably, the present invention uses *Fujikura fusiforme* as the starting strain and the nitrate reductase gene as the modified gene, which has high transformation efficiency and is more conducive to the screening of transformants. It also shows that the DNA random integration technology has good transformation efficiency in *Fujikura fusiforme*. Attached Figure Description
[0034] Figure 1 This is a spectrum of plasmid pUC57-T7-fcc1-FfniaD from Example 1;
[0035] Figure 2 This is a graph showing the gibberellin GA3 content in the fermentation broth of the 30 transformed strains in Example 2;
[0036] Figure 3 This is a process flow diagram of the method for identifying targets to increase gibberellin production in this invention. Detailed Implementation
[0037] The endpoints and any values of the ranges disclosed herein are not limited to the precise ranges or values, and these ranges or values should be understood to include values close to these ranges or values. For numerical ranges, the endpoint values of the various ranges, the endpoint values of the various ranges and individual point values, and individual point values can be combined with each other to obtain one or more new numerical ranges, which should be considered as specifically disclosed herein.
[0038] The first aspect of this invention provides a method for identifying targets that increase gibberellin production, see [link to relevant documentation]. Figure 3 The identification method includes the following steps:
[0039] (1) Knock out the modified gene in the starting strain to obtain a modified gene-deficient strain;
[0040] (2) Prepare protoplasts of the gene-deficient bacteria, randomly integrate the protoplasts with the gene through nonhomologous end joining (NHEJ) to obtain N transforming strains, and screen the N transforming strains to obtain the transforming strain with the highest gibberellin production as the target strain.
[0041] (3) The target strain is identified by reverse PCR to identify the integration target of the modified gene on the starting strain, so as to obtain the target for increasing gibberellin production.
[0042] The present invention provides a method for identifying targets for increasing gibberellin production. Based on a random integration method using non-terminal homologous recombination, molecular modification targets of gibberellin-producing bacteria are obtained. The modified gene expression cassette is introduced into gene-deficient bacteria using DNA random integration technology, causing the modified gene to randomly integrate into the chromosome of the gene-deficient bacteria, thereby forming multiple gene-deficient bacterial transformants. These transformants serve as a mutant library for gibberellin production. Fermentation experiments are conducted on the transformants to screen for high-yielding strains with increased gibberellin production. Reverse PCR technology is used to identify the location of the integrated modified gene in the chromosome, which is beneficial for identifying new targets for increasing gibberellin production. Simultaneously, the target strains obtained by this method can be used as recombinant strains with high gibberellin production.
[0043] According to the present invention, preferably, the modified gene is a nitrate reductase gene (niaD gene). More preferably, the nucleotide sequence of the nitrate reductase gene is shown in SEQ ID NO: 1.
[0044] During the research process, the inventors of this invention unexpectedly discovered that using the niaD gene as the modified gene resulted in mutant strains with high transformation efficiency, which was beneficial for screening transformants. Based on the final gibberellin yield, high-yielding gibberellin strains could be screened efficiently and rapidly. At the same time, reverse PCR was used to identify specific integration targets, revealing the intrinsic mechanism affecting gibberellin yield.
[0045] According to the present invention, the starting strain can be any strain that produces gibberellin. Preferably, the starting strain is *Gibberella fuciformis*, and more preferably, it is *Gibberella fuciformis* with accession number CCTCC NO: M2015614. The inventors have found that, under this preferred embodiment, it is advantageous to further increase the yield of gibberellin synthesized by the obtained target strain through fermentation.
[0046] According to the present invention, preferably, the knockout process in step (1) includes knocking out the modified gene using a CRISPR / Cas9 system. The inventors have found that this preferred embodiment is beneficial for improving the transformation efficiency of random DNA integration.
[0047] In this invention, the CRISPR / Cas9 system can employ existing components and methods. Specifically, the knockout backbone for knocking out the modified gene using the CRISPR / Cas9 system is a pFfCas9-sgRNA plasmid. The pFfCas9-sgRNA plasmid comprises the Cas9 gene, the promoter pTRPC, and the strong RNA polymerase III promoter 5srRNA. The internal design of the pFfCas9-sgRNA plasmid includes a stuⅠ site for inserting N20 into the nutrient selection marker niaD. More preferably, the nucleotide sequence of the sgRNA is shown in SEQ ID NO: 9, the nucleotide sequence of the 5s rRNA is shown in SEQ ID NO: 10, and the nucleotide sequence of N20 is shown in SEQ ID NO: 11.
[0048] In this invention, the preparation of protoplasts of the genetically modified defective bacteria can be carried out using existing methods. Exemplarily, the process of preparing protoplasts of the genetically modified defective bacteria includes: first, preparing an enzyme solution with a weight ratio of dryslase to lysing of 3:7; after filtering and sterilizing the enzyme solution, adding it to wet mycelia; placing it in a shaker at 25-35℃ at a speed of 50-70 rpm; taking samples every 0.5 h for microscopic observation of mycelial lysis and protoplast formation; after enzymatic hydrolysis, filtering the mycelia through lens paper; centrifuging the filtrate at 2500-3500 rpm for 8-12 min; discarding the supernatant; washing the protoplast precipitate with STC buffer; and finally storing it in STC buffer.
[0049] In this invention, the STC buffer consists of: sorbitol 180-185 g / L, anhydrous calcium chloride 0.4-0.7 g / L, Tris-base 0.1-0.15 g / L, and hydrochloric acid adjusted to pH 7-8.
[0050] According to the present invention, preferably, the NHEJ random integration process in step (2) includes: mixing the protoplast, the modified gene, polyethylene glycol 6000 (PEG6000), and STC buffer to obtain a suspension, and placing the suspension on a solid regeneration plate for transformation culture.
[0051] In this invention, protoplasts can be prepared into a solution using STC buffer and then mixed and suspended with the modified gene, PEG6000, and STC buffer.
[0052] According to the present invention, preferably, the culture medium of the solid regeneration plate contains: 15-25 g / L glucose, 5-8 g / L yeast basal medium, 0.5-1 g / L sodium nitrate, 15-25 g / L agar powder, and 0.3-0.8 mol / L sucrose.
[0053] According to the present invention, preferably, the conditions for the transformation culture include: a temperature of 25-30°C and a time of 4-6 days.
[0054] According to the present invention, preferably, the screening process in step (2) includes: sequentially performing subculture and fermentation culture I on the transformed strain. The subculture can be performed once or multiple times to obtain a stably subcultured transformed strain.
[0055] According to the present invention, the culture medium for the subculture is a solid regeneration culture medium. Preferably, the culture medium for the subculture contains: 15-25 g / L glucose, 5-8 g / L yeast basal medium, 0.5-1 g / L sodium nitrate, 15-25 g / L agar powder, and 0.3-0.8 mol / L sucrose.
[0056] According to the present invention, preferably, the subculture conditions include: a temperature of 25-30°C and a time of 4-6 days.
[0057] According to the present invention, before the fermentation culture I, the transformed strain obtained from subculture can be inoculated into seed culture medium I for activation culture I, so as to effectively activate and promote the growth of the transformed strain and improve the accurate characterization of the transformed strain's ability to produce gibberellin. The temperature, time, and other conditions of the activation culture I can be selected according to the type of the starting strain to suit the growth of the transformed strain. Preferably, the conditions of the activation culture I include: a temperature of 25-30℃ and a time of 40-60h.
[0058] According to the present invention, the components of the seed culture medium I and the fermentation culture medium I can be selected according to the type of the starting strain, and generally contain nutrients such as carbon source, nitrogen source, and metal salt. Preferably, the fermentation culture medium I in step (2) contains: carbon source 40-120 g / L, nitrogen source 25-40 g / L, soybean oil 0.8-1.6 g / L, MgSO4·7H2O 0.8-1.6 g / L, (NH4)2SO4 0.2-0.5 g / L, KH2PO4 1.5-4 g / L, ZnSO4 0.05-0.1 g / L, and MnSO4 0.05-0.1 g / L.
[0059] In this invention, the carbon source can be one or more of glucose, fructose, sucrose, etc., and the nitrogen source can be one or more of peptone, beef extract, yeast powder, yeast extract.
[0060] According to the present invention, the temperature, time, and other conditions of the fermentation culture I can be selected according to the type of the starting strain to suit the mass proliferation of the transformed strain. Preferably, the conditions of the fermentation culture I include: an inoculum size of 8-12% by volume, a temperature of 25-30°C, a rotation speed of 200-250 rpm, and a time of 8-12 days.
[0061] A second aspect of this invention provides the application of the above-described identification method in increasing gibberellin yield. Based on the identification method provided by this invention, it is possible to obtain the gene targets for increasing gibberellin yield in gibberellin-producing strains, providing a research basis for the modification of engineered bacteria for efficient gibberellin production.
[0062] The identification method provided by this invention can obtain target strains that express modified genes at the integration target site. Based on this, a third aspect of this invention provides a recombinant strain, which is the target strain obtained by treating the starting strain using the above-described identification method.
[0063] According to the present invention, preferably, the modified gene is a nitrate reductase gene, and the integration target is a dicarboxylic acid transporter site. The inventors have found that, under this preferred embodiment, it is beneficial to further increase the yield of gibberellin synthesized by the obtained target strain during fermentation.
[0064] According to the present invention, preferably, the nucleotide sequence of the nitrate reductase gene is as shown in SEQ ID NO: 1.
[0065] According to the present invention, preferably, the starting strain is *Fusarium oxysporum*, more preferably *Fusarium oxysporum* with accession number CCTCC NO: M2015614. The inventors have found that this preferred embodiment is beneficial for improving gibberellin production, providing a new platform for the metabolic engineering modification of *Fusarium oxysporum*.
[0066] The fourth aspect of the present invention provides a method for preparing gibberellin, the method comprising: inoculating the above-mentioned recombinant strain into a fermentation medium for fermentation culture II.
[0067] According to the present invention, before the fermentation culture II, the recombinant strain can be inoculated into seed culture medium II for activation culture II to effectively activate and promote the growth of the recombinant strain. The temperature, time, and other conditions of the activation culture II can be selected according to the type of recombinant strain to suit its growth. Preferably, the conditions of the activation culture II include: a temperature of 25-30°C and a time of 40-60 hours.
[0068] According to the present invention, the components of the seed culture medium II and the fermentation culture medium can be selected according to the type of recombinant strain, and generally contain nutrients such as carbon source, nitrogen source, and metal salt. Preferably, the fermentation culture medium contains: 40-120 g / L carbon source, 25-40 g / L nitrogen source, 0.8-1.6 g / L soybean oil, 0.8-1.6 g / L MgSO4·7H2O, 0.2-0.5 g / L (NH4)2SO4, 1.5-4 g / L KH2PO4, 0.05-0.1 g / L ZnSO4, and 0.05-0.1 g / L MnSO4.
[0069] According to the present invention, the temperature, time, and other conditions of the fermentation culture II can be selected according to the type of recombinant strain to suit the large-scale proliferation of the recombinant strain. Preferably, the conditions of the fermentation culture II include: an inoculum size of 8-12% by volume, a temperature of 25-30°C, a rotation speed of 200-250 rpm, and a time of 8-12 days.
[0070] According to the present invention, preferably, the fermentation medium contains: 40-120 g / L carbon source, 25-40 g / L nitrogen source, 0.8-1.6 g / L soybean oil, 0.8-1.6 g / L MgSO4·7H2O, 0.2-0.5 g / L (NH4)2SO4, 1.5-4 g / L KH2PO4, 0.05-0.1 g / L ZnSO4, and 0.05-0.1 g / L MnSO4. The inventors have found that this preferred embodiment is beneficial for improving the yield of gibberellin.
[0071] The present invention will be described in detail below through embodiments.
[0072] Unless otherwise specified, the experimental methods used in the following examples are conventional methods, and the reagents, methods and equipment used are conventional reagents, methods and equipment in this technical field.
[0073] In the following examples, the STC buffer consisted of: 182 g / L sorbitol, 0.555 g / L anhydrous calcium chloride, 0.121 g / L Tris-base, and pH adjusted to 7.5 with hydrochloric acid.
[0074] The solid regeneration medium consisted of: 20 g / L glucose, 6 g / L yeast basal medium, 0.8499 g / L sodium nitrate, 20 g / L agar powder, and 0.5 mol / L sucrose, with the pH adjusted to 6.5.
[0075] The seed culture medium consisted of: 80 g / L glucose, 30 g / L yeast extract, 1.2 g / L MgSO4·7H2O, 3 g / L KH2PO4, 0.08 g / L ZnSO4, and 0.08 g / L MnSO4.
[0076] The fermentation medium consisted of: 80 g / L glucose, 30 g / L yeast extract, 1.2 g / L soybean oil, 1.2 g / L MgSO4·7H2O, 0.3 g / L (NH4)2SO4, 3 g / L KH2PO4, 0.08 g / L ZnSO4, and 0.08 g / L MnSO4.
[0077] Example 1
[0078] (1) Using Fusarium fujikuroi NJtech02 (provided by Professor Ji Xiaojun's research group at Nanjing University of Technology, accession number CCTCC NO:M 2015614, disclosed in patent application CN105441340A) as the starting strain, the modified gene was knocked out using CRISPR / Cas9 technology to obtain a nitrate reductase gene knockout strain; wherein, the knockout backbone of the CRISPR / Cas9 system is pFfCas9-sgRNA plasmid, the components of pFfCas9-sgRNA plasmid include Cas9 gene, promoter pTRPC and strong RNA polymerase type III promoter 5S rRNA, and the internal design of the plasmid stuⅠ site is used to insert N20 in the nutrient selection marker niaD; the nucleotide sequence of sgRNA is shown in SEQ ID NO:9, the nucleotide sequence of 5S rRNA is shown in SEQ ID NO:10, and the nucleotide sequence of N20 is shown in SEQ ID NO:11;
[0079] (2) The pUC57-T7-fcc1 plasmid (nucleotide sequence as shown in SEQ ID NO: 2) was digested with EcoRⅠ to obtain a linearized plasmid backbone. Using primer pairs FfniaD-PCR-F (nucleotide sequence as shown in SEQ ID NO: 3) and FfniaD-PCR-R (nucleotide sequence as shown in SEQ ID NO: 4), a 4074bp fragment was amplified from the Fusarium graminearum genome (CCTCC NO: M 2015614). This fragment has 22bp homologous regions on both sides of the linearized plasmid backbone. Gibson assembly was performed using the Clone Express Ultra OneStep Cloning Kit cloning enzyme (purchased from Nanjing Novizan Biotechnology Co., Ltd.) to obtain the ligation solution. 20μL of the ligation solution was introduced into Escherichia coli DH5α competent cells, plated on LB plates (containing a final concentration of 100μg / mL ampicillin) and cultured overnight. Positive clones on the plates were selected and a primer pair pUC-tongyong-F (nucleotide sequence as shown in SEQ ID NO: 4) was used. PCR verification was performed on pUC-tongyong-R (nucleotide sequence shown in SEQ ID NO: 5) and pUC-tongyong-R (nucleotide sequence shown in SEQ ID NO: 6). The plasmids corresponding to the correct nucleotide bands were sent to Nanjing Qingke Company for Sanger DNA sequencing. The final plasmid pUC57-T7-fcc1-FfniaD (nucleotide sequence of niaD is shown in SEQ ID NO: 1, the Ff prefix indicates that this gene is an endogenous gene of Fusarium oxysporum) was obtained. Its plasmid map is shown below. Figure 1 As shown;
[0080] FfniaD-PCR-F:ttgtaaaacgacggccagtgaaGAGAGTTGCAGACTATAAGACAT ATG (SEQ IDNO: 3);
[0081] FfniaD-PCR-R:ttcgcgaggtaccgagctcgaaATATTGTTTGTTCATATGTACGTT CC (SEQ IDNO: 4);
[0082] pUC-tongyong-F:tcttcgctattacgccagct (SEQ ID NO: 5);
[0083] pUC-tongyong-R:caggaaacagctatgaccat (SEQ ID NO: 6);
[0084] (3) The FfniaD fragment was amplified using primers FfniaD-PCR-F and FfniaD-PCR-R. The DNA was recovered from the PCR reaction solution and concentrated to obtain a high concentration of linear FfniaD nucleotide fragment.
[0085] (4) Preparation of Fusarium oxysporum protoplasts: First, prepare an enzyme solution with a weight ratio of Dryslase to Lysing of 3:7. After filtering and sterilizing 10 mL of the enzyme solution, add 1 g of wet mycelium and place it in a shaker at 30 °C at 60 rpm. Take samples every 0.5 h for microscopic observation of mycelial lysis and protoplast formation. After enzymatic hydrolysis, filter the mycelium through lens paper, centrifuge the filtrate at 3000 rpm for 10 min, discard the supernatant, wash the protoplast precipitate with STC buffer, and finally store it in STC buffer as a protoplast solution.
[0086] Take 10 μL of the high-concentration linear FfniaD nucleotide fragment obtained in step (3) and add it to the protoplast solution. Add 1 mL of PEG6000 and let it stand on ice for 20 min. Then add 2 mL of STC buffer, suspend it, spread it on a solid regeneration medium plate, and culture it at 28℃ for 5 days to wait for transformant generation.
[0087] Example 2
[0088] The transformants obtained in Example 1 were passaged 15 times on solid regeneration medium (each passage was cultured at 28°C for 48 h) to obtain stable transformed strains. Thirty transformed strains were selected and inoculated into 30 mL of seed medium and cultured at 28°C for 48 h to obtain seed culture. Each seed culture was inoculated into 40 mL of fermentation medium at a volume of 10% and cultured continuously for 9 days in a shaker at 28°C and 220 rpm to obtain fermentation broth. The fermentation broth was centrifuged at 12000 rpm for 5 min to obtain supernatant. The supernatant was filtered through a 0.22 μm aqueous membrane and then placed in a liquid chromatography vial for HPLC analysis to detect the gibberellin GA3 yield in the fermentation broth of each transformed strain.
[0089] The gibberellin GA3 content in the fermentation broth of 30 transformed strains is as follows: Figure 2As shown in Table 1, using the starting strain as a control, a total of 6 transforming strains with no yield increase (the difference in GA3 yield between the transforming strain and the starting strain was less than 5 mg / g DCW), 9 transforming strains with increased yield (GA3 yield increased by more than 5 mg / g DCW compared to the starting strain), and 15 transforming strains with decreased yield (GA3 yield decreased by more than 5 mg / g DCW compared to the starting strain). Based on the results, it can be inferred that there are 6 new target sites that do not affect the cell production performance and 9 target sites that are beneficial to GA3 synthesis. This demonstrates that the DNA random integration platform constructed in this invention can operate efficiently in *Fusarium oxysporum*, facilitating subsequent target modification.
[0090] Table 1
[0091]
[0092]
[0093] Example 3
[0094] Transformed strain No. 29, which had the highest GA3 yield in Example 2 (as the target strain), was streaked on a YPD plate, and the genome of *Gibberella fuciformis* was extracted using a fungal genomic DNA extraction kit (purchased from Beijing Solarbio Science & Technology Co., Ltd.). Enzymatic digestion (3 μL of genomic DNA) was performed in a 10 μL system, and the isosigmazyme combination NheⅠ / XbaⅠ was selected (this enzyme includes a 6 bp degenerate site, which can increase the probability of circularization).
[0095] The restriction enzyme was inactivated by heat shock at 80°C, at which point the restriction enzyme no longer had the function of cutting nucleotide sequences. 10 μL of the restriction enzyme was added to 100 μL of T4 ligase self-circularization system, and the linearized fragment completed self-circularization, yielding the self-ligated product. Using the self-ligated product directly as a template, reverse PCR was performed in a 50 μL KOD amplification system using primer pairs niaD-PCR-F1 (nucleotide sequence as shown in SEQ ID NO: 7) and niaD-PCR-R2 (nucleotide sequence as shown in SEQ ID NO: 8) designed within the niaD gene (KOD amplification system composition: 1 μL KOD, 25 μL 2xBuffer, 10 μL 1M dNTP, 1.5 μL niaD-PCR-F1, 1.5 μL niaD-PCR-R1). KOD FX extension was performed for 3 min, followed by 40 cycles. Gel electrophoresis analysis was then performed. The single fragment was excised from the gel and the DNA fragment was recovered and sent to Nanjing Qingke Company for Sanger analysis. DNA sequencing and alignment of the sequence with the Fusarium graminearum genome sequence revealed that the niaD target was integrated at position XP_023429025.1. The XP_023429025.1 target encodes a carboxylic acid transport protein, which may increase GA3 production by influencing factors such as precursor efflux.
[0096] niaD-PCR-F1:CATCAACGCATACCAGCAATTG (SEQ ID NO: 7);
[0097] niaD-PCR-R2:GTCAATTGCTGGTATGCGTTGA (SEQ ID NO: 8).
[0098] Example 4
[0099] The target strain from Example 3 was used as the recombinant strain for producing Gibberellin. It was inoculated into 30 mL of seed culture medium and cultured at 28 °C for 48 h to obtain seed liquid. The seed liquid was inoculated into 40 mL of fermentation culture medium at a volume of 10% and cultured continuously in a shaker at 28 °C and 220 rpm for 9 days to obtain fermentation broth. The fermentation broth was centrifuged at 12000 rpm for 5 min to obtain supernatant. The supernatant was filtered through a 0.22 μm aqueous membrane and then placed in a liquid chromatography vial for HPLC analysis to detect the yield of gibberellin GA3 in the fermentation broth of the recombinant strain. The results are shown in Table 2.
[0100] Example 5
[0101] The target strain from Example 3 was used as a recombinant strain for producing *Fusarium graminearum*. It was inoculated into 30 mL of seed culture medium and cultured at 25°C for 60 h to obtain a seed culture. The seed culture was then inoculated into 40 mL of fermentation medium at an inoculation rate of 8% (the components of the fermentation medium were replaced with: glucose 40 g / L, yeast extract 40 g / L, soybean oil 1.6 g / L, MgSO4·7H2O 1.6 g / L, (NH4)2SO4 0.2 g / L, KH2PO4 1.5 g / L, ZnSO4 0.1 g / L, and MnSO4). The recombinant strain was cultured in 0.1 g / L solution for 12 days in a shaker at 25℃ and 250 rpm to obtain the fermentation broth. The fermentation broth was centrifuged at 12000 rpm for 5 min to obtain the supernatant. The supernatant was filtered through a 0.22 μm aqueous membrane and then placed in a liquid chromatography vial for HPLC analysis to detect the gibberellin GA3 yield in the fermentation broth. The results are shown in Table 2.
[0102] Example 6
[0103] The target strain from Example 3 was used as the recombinant strain for producing *Fusarium graminearum*. It was inoculated into 30 mL of seed culture medium and cultured at 30°C for 40 h to obtain a seed culture. The seed culture was then inoculated into 40 mL of fermentation medium at a volume percentage of 12% (the components of the fermentation medium were replaced with: glucose 120 g / L, yeast extract 25 g / L, soybean oil 0.8 g / L, MgSO4·7H2O 0.8 g / L, (NH4)2SO4 0.5 g / L, KH2PO4 4 g / L, ZnSO4 0.05 g / L, and MnSO4). The recombinant strain was cultured in 0.05 g / L solution for 8 days in a shaker at 30℃ and 200 rpm to obtain the fermentation broth. The fermentation broth was centrifuged at 12000 rpm for 5 min to obtain the supernatant. The supernatant was filtered through a 0.22 μm aqueous membrane and then placed in a liquid chromatography vial for HPLC analysis to detect the gibberellin GA3 yield in the fermentation broth. The results are shown in Table 2.
[0104] Example 7
[0105] Gibberellin was prepared by fermentation according to the method in Example 4, except that the components of the fermentation medium were replaced with: glucose 81.2 g / L, yeast extract 30 g / L, MgSO4·7H2O 1.2 g / L, (NH4)2SO4 0.3 g / L, KH2PO4 3 g / L, ZnSO4 0.08 g / L, and MnSO4 0.08 g / L.
[0106] Example 8
[0107] Gibberellin was prepared by fermentation according to the method in Example 4, except that the components of the fermentation medium were replaced with: glucose 80 g / L, yeast extract 30 g / L, soybean oil 3 g / L, MgSO4·7H2O 1.2 g / L, (NH4)2SO4 0.3 g / L, KH2PO4 3 g / L, ZnSO4 0.08 g / L, and MnSO4 0.08 g / L.
[0108] Comparative Example 1
[0109] Gibberellin was prepared by fermentation according to the method in Example 4, except that the recombinant strain was replaced with the original strain (accession number CCTCC NO: M2015614). The results are shown in Table 2.
[0110] Table 2
[0111] serial number Gibberellin GA3 yield in fermentation broth (mg / g DCW) Example 4 105.7 Example 5 98.5 Example 6 120.5 Example 7 92.3 Example 8 90.8 Comparative Example 1 60.2
[0112] The preferred embodiments of the present invention have been described in detail above; however, the present invention is not limited thereto. Within the scope of the inventive concept, various simple modifications can be made to the technical solutions of the present invention, including combinations of various technical features in any other suitable manner. These simple modifications and combinations should also be considered as the content disclosed in the present invention and are all within the protection scope of the present invention.
Claims
1. A recombinant bacterial strain, characterized in that, The nitrate reductase gene in the genome of the recombinant strain is integrated at a dicarboxylic acid transporter site, which is XP_023429025.1; the starting strain of the recombinant strain is Gibberella fujikuroi (Gibberella fujikuroi) Fusarium fujikuroi ), the nucleotide sequence of the nitrate reductase gene is shown as SEQ ID NO: 1; the preservation number of the Gibberella fujikuroi is CCTCC NO: M2015614.
2. The application of the recombinant strain according to claim 1 in increasing gibberellin yield.
3. A process for the preparation of gibberellins, characterized in that, The preparation method includes: inoculating the recombinant strain of claim 1 into a fermentation medium for fermentation culture.
4. The method of claim 3, wherein, The fermentation culture conditions include: an inoculum size of 8-12% by volume, a temperature of 25-30℃, a rotation speed of 200-250 rpm, and a time of 8-12 days; And / or, the fermentation medium contains: 40-120 g / L carbon source, 25-40 g / L nitrogen source, 0.8-1.6 g / L soybean oil, 0.8-1.6 g / L MgSO4·7H2O, 0.2-0.5 g / L (NH4)2SO4, 1.5-4 g / L KH2PO4, 0.05-0.1 g / L ZnSO4, and 0.05-0.1 g / L MnSO4.
Citation Information
Patent Citations
High-producing strain of GA (gibberellin) 4+7 and application of high-producing strain
CN105441340A
Selection by essential gene knock-in
CN115916968A
Pacilitaxel-producing microbe saturated mutant library construction and high yield pacilitaxel strain selection an breeding method
CN1800363A
